About the Authors
- Jianhua Sui
-
* E-mail: Jianhua_sui@dfci.harvard.edu (JS); Wayne_marasco@dfci.harvard.edu (WAM)
Affiliation Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
- Daniel R. Aird
-
Affiliation Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
- Azaibi Tamin
-
Affiliation National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
- Akikazu Murakami
-
Affiliation Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
- Meiying Yan
-
Affiliation State Key Laboratory for Infectious Disease Prevention and Control and National Institute for Communicable Disease Control and Prevention; Chinese Center for Disease Control and Prevention, Changping, Beijing, China
- Anuradha Yammanuru
-
Affiliation Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
- Huaiqi Jing
-
Affiliation State Key Laboratory for Infectious Disease Prevention and Control and National Institute for Communicable Disease Control and Prevention; Chinese Center for Disease Control and Prevention, Changping, Beijing, China
- Biao Kan
-
Affiliation State Key Laboratory for Infectious Disease Prevention and Control and National Institute for Communicable Disease Control and Prevention; Chinese Center for Disease Control and Prevention, Changping, Beijing, China
- Xin Liu
-
Affiliation Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
- Quan Zhu
-
Affiliation Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
- Qing-an Yuan
-
Affiliation Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America
- Gregory P. Adams
-
Affiliation Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America
- William J. Bellini
-
Affiliation National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
- Jianguo Xu
-
Affiliation State Key Laboratory for Infectious Disease Prevention and Control and National Institute for Communicable Disease Control and Prevention; Chinese Center for Disease Control and Prevention, Changping, Beijing, China
- Larry J. Anderson
-
Affiliation National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
- Wayne A. Marasco
-
* E-mail: Jianhua_sui@dfci.harvard.edu (JS); Wayne_marasco@dfci.harvard.edu (WAM)
Affiliation Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: JS WAM. Performed the experiments: JS DRA AT AM MY AY. Analyzed the data: JS WAM. Contributed reagents/materials/analysis tools: MY HJ BK QaY GPA. Wrote the paper: JS WAM. Involved in serological studies: MY. On Biacore study: AY. Analyzed antibody “hot spot” sequences: XL QZ. Involved in escape mutant study: WJB. Involved in serologic studies: JX. Involved in escape study and revised draft critically for antibody driving evolution of SARS-CoV: LJA.